Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prachi K Dandekar

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 4, 2003
Pharmacodynamic considerations for the selection of oral cephalosporins in the treatment of rhinosinusitisPrachi K Dandekar, David P Nicolau
Connecticut Medicine|February 21, 2002
Extended-spectrum beta-lactamases (ESBL)Prachi K Dandekar, Richard Quintiliani, Charles H Nightingale, et al.
Journal of Clinical Pharmacology|October 1, 2003
Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenemJoseph L Kuti, Prachi K Dandekar, Charles H Nightingale, et al.
Connecticut Medicine|April 12, 2003
Utilization of extended-spectrum beta-lactamase (ESBL) detection systems in microbiology laboratories: survey of Connecticut hospitals from 1998-2002Prachi K Dandekar, Nancy L Barrett, Charles H Nightingale, et al.
Pharmacotherapy|August 19, 2003
Pharmacokinetics of meropenem 0.5 and 2 g every 8 hours as a 3-hour infusionPrachi K Dandekar, Dana Maglio, Christina A Sutherland, et al.
Diagnostic Microbiology and Infectious Disease|May 12, 2004
Prevalence of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella isolates in a large community teaching hospital in ConnecticutPrachi K Dandekar, Janice Tetreault, John P Quinn, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection modelPrachi K Dandekar, Pamela R Tessier, Peter Williams, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2004
Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh modelPamela R Tessier, Holly M Mattoes, Prachi K Dandekar, et al.
International Journal of Antimicrobial Agents|September 8, 2005
Evaluation of telithromycin against Streptococcus pneumoniae with ribosomal mutations utilizing in vitro time-kill methodologyPrachi K Dandekar, Pamela R Tessier, David J Farrell, et al.
Chemotherapy|April 16, 2004
Determination of the pharmacodynamic profile of daptomycin against Streptococcus pneumoniae isolates with varying susceptibility to penicillin in a murine thigh infection modelPrachi K Dandekar, Pamela R Tessier, Peter Williams, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 4, 2003
Pharmacodynamic considerations for the selection of oral cephalosporins in the treatment of rhinosinusitisPrachi K Dandekar, David P Nicolau
Connecticut Medicine|February 21, 2002
Extended-spectrum beta-lactamases (ESBL)Prachi K Dandekar, Richard Quintiliani, Charles H Nightingale, et al.
Journal of Clinical Pharmacology|October 1, 2003
Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenemJoseph L Kuti, Prachi K Dandekar, Charles H Nightingale, et al.
Connecticut Medicine|April 12, 2003
Utilization of extended-spectrum beta-lactamase (ESBL) detection systems in microbiology laboratories: survey of Connecticut hospitals from 1998-2002Prachi K Dandekar, Nancy L Barrett, Charles H Nightingale, et al.
Pharmacotherapy|August 19, 2003
Pharmacokinetics of meropenem 0.5 and 2 g every 8 hours as a 3-hour infusionPrachi K Dandekar, Dana Maglio, Christina A Sutherland, et al.
Diagnostic Microbiology and Infectious Disease|May 12, 2004
Prevalence of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella isolates in a large community teaching hospital in ConnecticutPrachi K Dandekar, Janice Tetreault, John P Quinn, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection modelPrachi K Dandekar, Pamela R Tessier, Peter Williams, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2004
Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh modelPamela R Tessier, Holly M Mattoes, Prachi K Dandekar, et al.
International Journal of Antimicrobial Agents|September 8, 2005
Evaluation of telithromycin against Streptococcus pneumoniae with ribosomal mutations utilizing in vitro time-kill methodologyPrachi K Dandekar, Pamela R Tessier, David J Farrell, et al.
Chemotherapy|April 16, 2004
Determination of the pharmacodynamic profile of daptomycin against Streptococcus pneumoniae isolates with varying susceptibility to penicillin in a murine thigh infection modelPrachi K Dandekar, Pamela R Tessier, Peter Williams, et al.
Pageof 2